Clinical Trial Update: Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update on bismuth-metronidazole triple therapy as first-line treatment for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth-metronidazole triple therapy

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN